Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study.
Saved in:
| Title: | Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study. |
|---|---|
| Authors: | Signorelli, Carlo1 (AUTHOR) carlo.signorelli@asl.vt.it, Basso, Michele2 (AUTHOR), Calegari, Maria Alessandra2,3 (AUTHOR), Anghelone, Annunziato2,4 (AUTHOR), Passardi, Alessandro3,5 (AUTHOR), Gallio, Chiara3,6 (AUTHOR), Bittoni, Alessandro3,7 (AUTHOR), Lucchetti, Jessica4,8 (AUTHOR), Angotti, Lorenzo4,9 (AUTHOR), Di Giacomo, Emanuela4,10 (AUTHOR), Zurlo, Ina Valeria5,11 (AUTHOR), Morelli, Cristina6,12 (AUTHOR), Dell'Aquila, Emanuela7,13 (AUTHOR), Artemi, Adele7,14 (AUTHOR), Gemma, Donatello8,15 (AUTHOR), Emiliani, Alessandra9,16 (AUTHOR), Ribelli, Marta9,17 (AUTHOR), Corsi, Domenico Cristiano9,18 (AUTHOR), Arrivi, Giulia10,19 (AUTHOR), Mazzuca, Federica10,20 (AUTHOR) |
| Source: | Cancers. Oct2025, Vol. 17 Issue 20, p3316. 21p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
